Listed by the USPTO as GIERE, REBECCA M
Tech Center 1700 • Art Units: 1622 1638 1641 1657 1677 1796 1799
This examiner grants 74% of resolved cases
GIERE, REBECCA M is assigned to Technology Center 1700 and Art Unit 1622. Across 518 resolved cases, the allowance rate is 73.7%, and the median time to allowance is 1119 days. The interview lift is 32.3%, indicating that interviews have a substantial positive association with allowance outcomes in the profile.
The principal companies are Zoetis LLC, Fujifilm Corporation, and Abbott Laboratories. The leading firms are BIRCH STEWART KOLASCH & BIRCH, LLP, Shackelford, Bowen, McKinley & Norton (Amini), and CASIMIR JONES, S.C. The outcome pattern supports treating examiner interviews as an important part of prosecution planning, particularly where technical or claim-scope issues may benefit from direct discussion. The median timeline also supports early attention to response sequencing and continuation decisions. The affiliations point to life-science and imaging matters.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17859292 | IMMUNOLOGICAL TEST METHOD | Final Rejection | FUJIFILM Corporation |
| 18331697 | NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO | Final Rejection | Zoetis Services LLC |
| 18174251 | SIGNAL AMPLIFICATION IN SOLUTION-BASED PLASMONIC SPECIFIC-BINDING PARTNER ASSAYS | Non-Final OA | Zoetis Services LLC |
| 18509717 | BIOMARKERS FOR USE IN DETERMINING TRAUMATIC BRAIN INJURY (TBI) | Non-Final OA | Abbott Laboratories |
| 18560106 | METHODS OF ANALYZING SHAPED PARTICLES CONTAINING CELLS USING FLUORESCENCE ACTIVATED CELL SORTING | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19045994 | NANOSENSOR METHODS AND APPARATUSES FOR DETERMINATION OF ANALYTES | Non-Final OA | President and Fellows of Harvard College |
| 18612744 | NANOPORE BASED MOLECULAR DETECTION AND SEQUENCING | Non-Final OA | Roche Sequencing Solutions, Inc. |
| 18273153 | IMMUNOLOGICAL ASSAY METHOD | Final Rejection | SEKISUI MEDICAL CO., LTD. |
| 18027202 | 3D-PRINTED MODULAR MICROCHIP WITH AN INTEGRATED IMPELLER PUMP TO MODEL INTER-ORGAN COMMUNICATION | Non-Final OA | University of Virginia Patent Foundation |
| 18372558 | BIOSENSOR FOR DETECTING A SINGLE MAGNETIC LABEL | Non-Final OA | UNIVERSITY OF HOUSTON SYSTEM |
| 18042032 | MICROFLUIDIC ASSAY DEVICE | Non-Final OA | Duke University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy73.7% of resolved applications examined by Rebecca M Giere were allowed (518 resolved cases), compared with 60.6% across Art Unit 1622 over the last five years.
This examiner's interview lift is +32.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rebecca M Giere took 1,119 days on average from filing to allowance.
Rebecca M Giere examines applications in Art Unit 1622 in Tech Center 1700 (Chemistry & Materials).
